AMAZON COM INC
Long book
$2.63B
Q1 2026
Positions
5
Top-10 weight
100%
concentration
Last quarter
+28.3%
SPY +14.8%
Turnover
17%
of book per quarter
Strategy in plain words
auto-generated from filingsAMAZON COM INC is a concentrated fundamental stock-picker, specialised in industrials (97% of the long book), running a $2.63B US long book across 5 positions.
The portfolio is extremely concentrated — the top 10 positions are almost the whole book. Turnover is modest: positions are typically held for years. Current anchor positions: RIVIAN AUTOMOTIVE INC-A, BETA TECHNOLOGIES INC -CL A, MARVELL TECHNOLOGY INC, ASTERA LABS INC, NAUTILUS BIOTECHNOLOGY INC.
Over the last 9 quarters its long book ran on average 4.2pp per quarter ahead of the S&P 500, beating the index in 6 of 9 quarters. We rate its filings highest-signal: new buys here are worth attention.
Implied long-book return vs S&P 500
methodology: positions priced quarterly, no shorts/options Fund long book S&P 500
Q1 2024
+21.1%
Q2 2024
-14.9%
Q3 2024
+25.1%
Q4 2024
-8.1%
Q1 2025
+12.2%
Q2 2025
+8.9%
Q3 2025
+31.5%
Q4 2025
-25.7%
Q1 2026
+28.3%
Sector allocation
Industrials 97%
Technology 3%
Healthcare 0%
Long book by quarter
What does AMAZON COM own?
Q1 2026 13F| Company | Sector | Shares | Value | % of book | Change |
|---|---|---|---|---|---|
| RIVN RIVIAN AUTOMOTIVE INC-A | Industrials | 158.4M | $2.38B | 90.6% | Held |
| BETA BETA TECHNOLOGIES INC -CL A | Industrials | 11.8M | $172.8M | 6.6% | Held |
| MRVL MARVELL TECHNOLOGY INC | Technology | 396.4K | $39.3M | 1.5% | +75.8% |
| ALAB ASTERA LABS INC | Technology | 277.8K | $30.4M | 1.2% | Held |
| NAUT NAUTILUS BIOTECHNOLOGY INC | Healthcare | 1.5M | $5.7M | 0.2% | Held |
13F filing history
| Period | Form | Filed | Entries | Reported value | Flags | Source |
|---|---|---|---|---|---|---|
| Q1 2026 | 13F-HR | May 5, 2026 | 5 | $2.63B | canonical | SEC ↗ |
| Q4 2025 | 13F-HR | Feb 10, 2026 | 6 | $3.52B | canonical | SEC ↗ |
| Q3 2025 | 13F-HR | Nov 4, 2025 | 7 | $2.46B | canonical | SEC ↗ |
| Q2 2025 | 13F-HR | Aug 5, 2025 | 9 | $2.43B | canonical | SEC ↗ |
| Q1 2025 | 13F-HR | May 6, 2025 | 9 | $2.42B | canonical | SEC ↗ |
| Q4 2024 | 13F-HR | Feb 7, 2025 | 9 | $2.70B | canonical | SEC ↗ |
| Q3 2024 | 13F-HR | Nov 7, 2024 | 10 | $2.21B | canonical | SEC ↗ |
| Q2 2024 | 13F-HR | Jul 30, 2024 | 10 | $2.53B | canonical | SEC ↗ |
| Q1 2024 | 13F-HR | Apr 29, 2024 | 10 | $2.12B | canonical | SEC ↗ |